{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T16:22:59Z","timestamp":1788452579018,"version":"build-2803163510"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81370991"],"award-info":[{"award-number":["81370991"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81570818"],"award-info":[{"award-number":["81570818"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Eye Research"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.exer.2020.107982","type":"journal-article","created":{"date-parts":[[2020,2,21]],"date-time":"2020-02-21T13:25:51Z","timestamp":1582291551000},"page":"107982","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Keratocytes promote corneal neovascularization through VEGFr3 induced by PPAR\u03b1-inhibition"],"prefix":"10.1016","volume":"193","author":[{"given":"Xue","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liying","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoqiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wensheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongxiong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exer.2020.107982_bib1","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1038\/eye.2015.159","article-title":"Defining response to anti-VEGF therapies in neovascular AMD","volume":"29","author":"Amoaku","year":"2015","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.exer.2020.107982_bib2","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1111\/j.1582-4934.2008.00415.x","article-title":"A pro-inflammatory signature mediates FGF2-induced angiogenesis","volume":"13","author":"Andres","year":"2009","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.exer.2020.107982_bib3","doi-asserted-by":"crossref","first-page":"17763","DOI":"10.1038\/s41598-017-18113-3","article-title":"Peroxisome proliferator-activated receptor alpha agonist suppresses neovascularization by reducing both vascular endothelial growth factor and angiopoietin-2 in corneal alkali burn","volume":"7","author":"Arima","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.exer.2020.107982_bib4","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1074\/jbc.275.4.2837","article-title":"Regulation of cyclooxygenase-2 by hypoxia and peroxisome proliferators in the corneal epithelium","volume":"275","author":"Bonazzi","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.exer.2020.107982_bib5","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/00055735-200108000-00002","article-title":"Corneal neovascularization","volume":"12","author":"Chang","year":"2001","journal-title":"Curr. Opin. Ophthalmol."},{"key":"10.1016\/j.exer.2020.107982_bib6","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1097\/01.ico.0000183485.85636.ff","article-title":"Time course of angiogenesis and lymphangiogenesis after brief corneal inflammation","volume":"25","author":"Cursiefen","year":"2006","journal-title":"Cornea"},{"key":"10.1016\/j.exer.2020.107982_bib7","doi-asserted-by":"crossref","first-page":"821592","DOI":"10.1155\/2008\/821592","article-title":"PPAR-alpha ligands as potential therapeutic agents for wet age-related macular degeneration","volume":"2008","author":"Del","year":"2008","journal-title":"PPAR Res."},{"key":"10.1016\/j.exer.2020.107982_bib8","doi-asserted-by":"crossref","first-page":"5030","DOI":"10.1167\/iovs.16-21402","article-title":"Therapeutic effects of a novel agonist of peroxisome proliferator-activated receptor alpha for the treatment of diabetic retinopathy","volume":"58","author":"Deng","year":"2017","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2020.107982_bib9","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1016\/j.ajpath.2014.06.021","article-title":"Peroxisome proliferator-activated receptor alpha protects capillary pericytes in the retina","volume":"184","author":"Ding","year":"2014","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.exer.2020.107982_bib10","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/eye.2013.107","article-title":"Adverse events and complications associated with intravitreal injection of anti-VEGF agents: a review of literature","volume":"27","author":"Falavarjani","year":"2013","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.exer.2020.107982_bib11","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1194\/jlr.M041988","article-title":"Upregulation of hepatic VLDLR via PPARalpha is required for the triglyceride-lowering effect of fenofibrate","volume":"55","author":"Gao","year":"2014","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.exer.2020.107982_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/eye.2016.208","article-title":"Risk of geographic atrophy in age-related macular degeneration patients treated with intravitreal anti-VEGF agents","volume":"31","author":"Gemenetzi","year":"2017","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.exer.2020.107982_bib13","doi-asserted-by":"crossref","first-page":"15401","DOI":"10.1073\/pnas.1307211110","article-title":"Pathogenic role of diabetes-induced PPAR-alpha down-regulation in microvascular dysfunction","volume":"110","author":"Hu","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.exer.2020.107982_bib14","doi-asserted-by":"crossref","first-page":"6691","DOI":"10.1167\/iovs.14-14746","article-title":"Keratocytes create stromal spaces to promote corneal neovascularization via MMP13 expression","volume":"55","author":"Ma","year":"2014","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2020.107982_bib15","doi-asserted-by":"crossref","first-page":"3968","DOI":"10.2337\/db13-0800","article-title":"An update on the molecular actions of fenofibrate and its clinical effects on diabetic retinopathy and other microvascular end points in patients with diabetes","volume":"62","author":"Noonan","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.exer.2020.107982_bib16","first-page":"2402","article-title":"The role of macrophage migration inhibitory factor in ocular surface disease pathogenesis after chemical burn in the murine eye","volume":"16","author":"Oh","year":"2010","journal-title":"Mol. Vis."},{"key":"10.1016\/j.exer.2020.107982_bib17","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1073\/pnas.0711281105","article-title":"PPARalpha agonist fenofibrate suppresses tumor growth through direct and indirect angiogenesis inhibition","volume":"105","author":"Panigrahy","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.exer.2020.107982_bib18","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1089\/jop.2013.0206","article-title":"Safety monitoring of ophthalmic biologics: a systematic review of pre- and postmarketing safety data","volume":"30","author":"Penedones","year":"2014","journal-title":"J. Ocul. Pharmacol. Therapeut. off. J. Assoc.Ocular Pharmacol. Therapeut."},{"key":"10.1016\/j.exer.2020.107982_bib19","first-page":"2514","article-title":"Expression of vascular endothelial growth factor and its receptors in inflamed and vascularized human corneas","volume":"41","author":"Philipp","year":"2000","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2020.107982_bib20","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1097\/00041433-200110000-00006","article-title":"Peroxisome proliferator-activated receptors in endothelial cell biology","volume":"12","author":"Plutzky","year":"2001","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.exer.2020.107982_bib21","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1097\/00041433-200110000-00006","article-title":"Peroxisome proliferator-activated receptors in endothelial cell biology","volume":"12","author":"Plutzky","year":"2001","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.exer.2020.107982_bib22","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1476-4598-5-13","article-title":"In vitro and in vivo effects of the PPAR-alpha agonists fenofibrate and retinoic acid in endometrial cancer","volume":"5","author":"Saidi","year":"2006","journal-title":"Mol. Canc."},{"key":"10.1016\/j.exer.2020.107982_bib23","doi-asserted-by":"crossref","first-page":"5494","DOI":"10.1167\/iovs.18-24504","article-title":"Sleep deprivation induces dry eye through inhibition of PPARalpha expression in corneal epithelium","volume":"59","author":"Tang","year":"2018","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2020.107982_bib24","doi-asserted-by":"crossref","first-page":"236","DOI":"10.4103\/2231-4040.90879","article-title":"The peroxisome proliferator-activated receptor: a family of nuclear receptors role in various diseases","volume":"2","author":"Tyagi","year":"2011","journal-title":"J Adv Pharm Technol Res"},{"key":"10.1016\/j.exer.2020.107982_bib25","doi-asserted-by":"crossref","first-page":"347","DOI":"10.3109\/09286586.2014.949010","article-title":"Predicting non-response to ranibizumab in patients with neovascular age-related macular degeneration","volume":"21","author":"van Asten","year":"2014","journal-title":"Ophthalmic Epidemiol."}],"container-title":["Experimental Eye Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001448351930716X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001448351930716X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T05:06:31Z","timestamp":1757999191000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001448351930716X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":25,"alternative-id":["S001448351930716X"],"URL":"https:\/\/doi.org\/10.1016\/j.exer.2020.107982","relation":{},"ISSN":["0014-4835"],"issn-type":[{"value":"0014-4835","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Keratocytes promote corneal neovascularization through VEGFr3 induced by PPAR\u03b1-inhibition","name":"articletitle","label":"Article Title"},{"value":"Experimental Eye Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exer.2020.107982","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107982"}}